Epsilon Healthcare Ltd (EPN) - Total Assets
Based on the latest financial reports, Epsilon Healthcare Ltd (EPN) holds total assets worth AU$17.87 Million AUD (≈ $12.64 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See EPN total equity for net asset value and shareholders' equity analysis.
Epsilon Healthcare Ltd - Total Assets Trend (2016–2025)
This chart illustrates how Epsilon Healthcare Ltd's total assets have evolved over time, based on quarterly financial data.
Epsilon Healthcare Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Epsilon Healthcare Ltd's total assets of AU$17.87 Million consist of 29.5% current assets and 70.5% non-current assets.
| Asset Category | Amount (AUD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$0.00 | 1.4% |
| Accounts Receivable | AU$3.52 Million | 19.7% |
| Inventory | AU$1.20 Million | 6.7% |
| Property, Plant & Equipment | AU$12.16 Million | 68.1% |
| Intangible Assets | AU$0.00 | 0.0% |
| Goodwill | AU$0.00 | 0.0% |
Asset Composition Trend (2016–2025)
This chart illustrates how Epsilon Healthcare Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Epsilon Healthcare Ltd.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Epsilon Healthcare Ltd's current assets represent 29.5% of total assets in 2025, a decrease from 41.0% in 2016.
- Cash Position: Cash and equivalents constituted 1.4% of total assets in 2025, down from 31.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 58.0% in 2016.
- Asset Diversification: The largest asset category is property, plant & equipment at 68.1% of total assets.
Epsilon Healthcare Ltd Competitors by Total Assets
Key competitors of Epsilon Healthcare Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Swedish Orphan Biovitrum AB (publ)
ST:SOBI
|
Sweden | Skr67.43 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
|
USA | $5.76 Million |
|
Shan Dong Dong-E E-Jiao Co Ltd
SHE:000423
|
China | CN¥12.75 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Henan Newland Pharmaceutical Co. Ltd. A
SHE:301277
|
China | CN¥1.77 Billion |
Epsilon Healthcare Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.14 | 0.32 | 1.73 |
| Quick Ratio | 0.88 | 0.27 | 1.39 |
| Cash Ratio | 0.00 | 0.00 | 1.14 |
| Working Capital | AU$654.53K | AU$-7.81 Million | AU$4.46 Million |
Epsilon Healthcare Ltd - Advanced Valuation Insights
This section examines the relationship between Epsilon Healthcare Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.86 |
| Latest Market Cap to Assets Ratio | 0.31 |
| Asset Growth Rate (YoY) | -19.7% |
| Total Assets | AU$17.87 Million |
| Market Capitalization | $5.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values Epsilon Healthcare Ltd's assets below their book value (0.31x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Epsilon Healthcare Ltd's assets decreased by 19.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Epsilon Healthcare Ltd (2016–2025)
The table below shows the annual total assets of Epsilon Healthcare Ltd from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | AU$17.87 Million ≈ $12.64 Million |
-19.74% |
| 2024-12-31 | AU$22.26 Million ≈ $15.75 Million |
+54.46% |
| 2023-12-31 | AU$14.41 Million ≈ $10.20 Million |
-29.70% |
| 2022-12-31 | AU$20.50 Million ≈ $14.51 Million |
-32.90% |
| 2021-12-31 | AU$30.55 Million ≈ $21.62 Million |
-18.01% |
| 2020-12-31 | AU$37.26 Million ≈ $26.37 Million |
+33.97% |
| 2019-12-31 | AU$27.81 Million ≈ $19.68 Million |
-15.06% |
| 2018-12-31 | AU$32.75 Million ≈ $23.17 Million |
+49.21% |
| 2017-12-31 | AU$21.95 Million ≈ $15.53 Million |
+91.50% |
| 2016-12-31 | AU$11.46 Million ≈ $8.11 Million |
-- |
About Epsilon Healthcare Ltd
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in two segments, Contract Development and Manufacturing Activities; and Telehealth Medical Practice Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmace… Read more